Clinical Trials Logo

Wounds and Injuries clinical trials

View clinical trials related to Wounds and Injuries.

Filter by:

NCT ID: NCT05110092 Enrolling by invitation - Quality of Life Clinical Trials

Breathing-based Leg Resistance Exercise Improves Wound Healing, Blood Sugar and Quality of Life for Diabetic Foot Ulcers

Start date: December 14, 2016
Phase: N/A
Study type: Interventional

The purpose of the study was designed leg resistance training combined with breathing approach, and evaluated its effect on wound healing, blood sugar control and quality of life in type 2 diabetic patients with foot ulcers.

NCT ID: NCT05080608 Enrolling by invitation - Nerve Injury Clinical Trials

Nerve Injury in the Hand, an Interview Study

Start date: May 1, 2021
Phase:
Study type: Observational

This qualitative study sought to explore the exerience of change in physical activity due to nerve injury in the arm and hand.

NCT ID: NCT05074212 Enrolling by invitation - Wound Heal Clinical Trials

Aesthetic Outcome of Complex Linear Closure vs Second Intention Healing: Below the Knee

Start date: January 10, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether complex linear closure vs second intention healing for cutaneous wounds below the knee affects esthetic outcomes (primary outcome). As secondary outcome, the study team plans to look at patient quality of life measures and complications. This will be a prospective, 2-arm, randomized, evaluator-blinded clinical trial. One half of the patients will receive repair by complex linear closure and the other half of the patients will undergo second intention healing. Three-months post-surgery, the scar will be evaluated via the patient observer scar assessment scale (POSAS), a validated scar instrument, as well as the trace-to-tape method, an objective outcome measure for linear postoperative scars. In addition, patients will be provided a validated quality of life survey to complete. Any adverse events will also be recorded.

NCT ID: NCT05047120 Enrolling by invitation - Clinical trials for Spinal Cord Injuries

Hypnotic Cognitive Therapy Reduce Acute & Chronic SCI Pain in Inpatient Rehabilitation

HYPCT
Start date: September 18, 2023
Phase: N/A
Study type: Interventional

Chronic spinal cord injury (SCI) pain is complex and difficult to treat. For individuals with SCI, pain often begins early in the course of their SCI and continues longitudinally. Unfortunately, SCI-related pain is frequently not responsive to medical treatment and medical treatments that are available and commonly used, such as opioids, have negative side-effects and risk of addiction. Nonpharmacological (non-medication) interventions to reduce chronic pain show promise both for individuals with SCI as well as other chronic pain conditions. Research on psychological interventions for chronic pain over the past two decades has consistently found these interventions to be more effective than no treatment, standard care, pain education, or relaxation training alone. However, many of these interventions are designed and implemented in outpatient settings after chronic pain has already developed. The development of early, effective, and preventative interventions to reduce the development of chronic pain has the potential to vastly improve quality of life for individuals with SCI. Having demonstrated the feasibility and acceptance of this treatment in an earlier study, the purpose of this randomized clinical trial is to compare the treatment of Hypnosis Enhanced Cognitive (HYPCT) therapy to Pain Education (ED) for reducing acute and chronic pain for individuals with new spinal cord injuries. The main goals of the study are to: - Aim 1: Test the effectiveness of HYPCT during inpatient rehabilitation for SCI compared to a ED for reducing current pain intensity. - Aim 2: Determine the post-intervention impact of HYPCT sessions compared to ED on average pain intensity. Participants will be asked to: - Complete 4 surveys over seven months - Complete pre and post treatment pain assessments for each of 4 treatment/control sessions Participants will be assigned to one of two groups for treatment and receive either: - 4 Hypnotic Cognitive therapy sessions or - 4 Pain Education sessions

NCT ID: NCT05034718 Enrolling by invitation - Brain Injury Clinical Trials

Implementation of the Pittsburgh Infant Brain Injury Score

PIBIS
Start date: July 5, 2021
Phase: N/A
Study type: Interventional

This is an implementation study of the Pittsburgh Infant Brain Injury Score (PIBIS) into the UPMC Children's Hospital of Pittsburgh emergency department. Children less than 1 year of age presenting to the CHP ED for symptoms which place them at increased risk for AHT as defined in the PIBIS validation study will be potentially eligible.

NCT ID: NCT05032378 Enrolling by invitation - Stroke Clinical Trials

Motion Sensor and Feedback System Efficacy to Refine Movements After Injury

Start date: December 17, 2021
Phase:
Study type: Observational

The purpose of these case studies is to determine the efficacy of the Kinesthetic Awareness Training (KAT) device in facilitating the restoration of desired movement patterns when people with acquired central nervous system damage perform functional activities such as walking, transitioning from one position to another, or reaching with the arms.

NCT ID: NCT04956536 Enrolling by invitation - Clinical trials for Anterior Cruciate Ligament Injuries

Anterior Tibial Subluxation in the Setting of ACL-injury and After ACL Reconstruction

Start date: December 1, 2020
Phase:
Study type: Observational

To identify the related factors for anterior tibial subluxation (ATS) on anterior cruciate ligament-injured MRI images.

NCT ID: NCT04933149 Enrolling by invitation - Clinical trials for Brachial Plexus Injury

Ketamine Infusion for Neuropathic Pain in Brachial Plexus Injuries

Start date: December 15, 2021
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess pre- and postoperative neuropathic pain in patients with traumatic brachial plexus injuries to determine if intraoperative ketamine infusion affect neuropathic pain associated with avulsion injuries of the brachial plexus.

NCT ID: NCT04930822 Enrolling by invitation - Stroke Clinical Trials

Evaluation of Bioness Integrated Therapy System (BITS) Touch Screen Technology to Improve Field Awareness

Start date: January 8, 2021
Phase: N/A
Study type: Interventional

The Bioness Integrated Therapy System (BITS) (Bioness Inc. Valencia, CA) Touch Screen is an FDA approved device comprised of an interactive touchscreen and diverse program options to challenge patients through the use of visual motor activities, visual and auditory processing, cognitive skills, and endurance training. The purpose of this study is to enroll a small group of adults currently undergoing inpatient rehabilitation, who were admitted for an acute neurological event and present with an acute neurological visual field impairment. The primary objective is to compare any increase in visual field awareness using a prescribed regimen consisting of conventional vision exercises compared with a regimen using BITS touch screen technology. Participants will be alternately assigned into "A" and "B" groups upon enrollment. The control group "A" will be prescribed conventional (table top, pen and paper) vision interventions provided by an occupational therapist and will receive pre- and post- assessment of visual field awareness. Treatment group "B" will include a prescribed regimen with use of BITS touch screen technology. Group B participants will receive the same pre- and post- assessment of visual field awareness as Group A participants. The hypothesis is that incorporation of the BITS touch screen technology, being more interactive, will result in better outcomes for visual field awareness. This is an unblinded quasi-randomized control trial that will determine best treatment intervention for visual field impairment. Safety will be measured by the number of reported adverse events. The study period will include 6 sessions per participant, conducted at one site, with the objective of enrolling at least 30 participants to have 15 participants in each study group.

NCT ID: NCT04886882 Enrolling by invitation - Wound Heal Clinical Trials

Topical Agents Containing Magnesium Sulfate & Wound Healing in the Rat Model

Start date: March 22, 2021
Phase: Early Phase 1
Study type: Interventional

An experimental study examining wound healing in 5 different groups on 30 rats.